Bioventus Company Insiders

Bioventus Management Team Effectiveness

The company has Return on Asset of 0.0324 % which means that on every $100 spent on assets, it made $0.0324 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.2155) %, meaning that it generated no profit with money invested by stockholders. Bioventus' management efficiency ratios could be used to measure how well Bioventus manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.16 in 2025. Return On Capital Employed is likely to gain to -0.14 in 2025. At this time, Bioventus' Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 568 M in 2025, whereas Total Current Assets are likely to drop slightly above 222.1 M in 2025. Net Income Applicable To Common Shares is likely to gain to about 23.4 M in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 64.4 M in 2025.

Bioventus Workforce Comparison

Bioventus Profit Margins

The company has Net Profit Margin of (0.06) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of 0.07 %, which entails that for every 100 dollars of revenue, it generated $0.07 of operating income.

Bioventus Insider Trading History

Bioventus Notable Stakeholders

The success or failure of an entity such as Bioventus often depends on how effective the management is. Bioventus management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Bioventus management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Bioventus management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Bioventus' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Bioventus. Check Bioventus' Beneish M Score to see the likelihood of Bioventus' management manipulating its earnings.

When running Bioventus' price analysis, check to measure Bioventus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioventus is operating at the current time. Most of Bioventus' value examination focuses on studying past and present price action to predict the probability of Bioventus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioventus' price. Additionally, you may evaluate how the addition of Bioventus to your portfolios can decrease your overall portfolio volatility.